⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12947991 | 1.00 | — | — | |
| SCHEMBL10489369 | 1.00 | — | — | |
| SCHEMBL25152636 | 0.84 | — | — | |
| SCHEMBL14079710 | 0.81 | CHRNA7 (0.36) | — | |
| SCHEMBL13560157 | 0.81 | CHRNA7 (0.36) | — | |
| SCHEMBL23710744 | 0.81 | CHRNA7 (0.36) | — | |
| SCHEMBL15795597 | 0.78 | — | — | |
| SCHEMBL31330779 | 0.78 | — | — | |
| SCHEMBL5860288 | 0.78 | — | — | |
| SCHEMBL6029549 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023133229-A2 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | REMIX THERAPEUTICS INC. (US) | 2023-07-13 | — | — | WO | disclosed |
| US-20230140983-A1 | PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING | REMIX THERAPEUTICS INC (US) | 2023-05-11 | — | — | US | disclosed |